Connection

Donald Castell to Gastric Acidity Determination

This is a "connection" page, showing publications Donald Castell has written about Gastric Acidity Determination.
Connection Strength

3.276
  1. Monitoring for GE Reflux: Is Normal the New Normal? Dig Dis Sci. 2015 May; 60(5):1118-9.
    View in: PubMed
    Score: 0.490
  2. Characteristics of symptomatic reflux episodes on Acid suppressive therapy. Am J Gastroenterol. 2008 May; 103(5):1090-6.
    View in: PubMed
    Score: 0.301
  3. Simultaneous intraesophageal impedance and pH measurement of acid and nonacid gastroesophageal reflux: effect of omeprazole. Gastroenterology. 2001 Jun; 120(7):1599-606.
    View in: PubMed
    Score: 0.187
  4. Sporadic Fundic Gland Polyps and Gastric Acid Suppression Level. Am J Med Sci. 2017 12; 354(6):561-564.
    View in: PubMed
    Score: 0.143
  5. Accurate measurement of gastric acidity. Am J Gastroenterol. 1997 Jan; 92(1):181.
    View in: PubMed
    Score: 0.137
  6. Changes in overnight fasting intragastric pH show poor correlation with duodenogastric bile reflux in normal subjects. Am J Gastroenterol. 1996 Aug; 91(8):1567-70.
    View in: PubMed
    Score: 0.134
  7. Addition of a H2 receptor antagonist to PPI improves acid control and decreases nocturnal acid breakthrough. J Clin Gastroenterol. 2008 Jul; 42(6):676-9.
    View in: PubMed
    Score: 0.076
  8. An analysis of persistent symptoms in acid-suppressed patients undergoing impedance-pH monitoring. Clin Gastroenterol Hepatol. 2008 May; 6(5):521-4.
    View in: PubMed
    Score: 0.075
  9. Review article: complete gastro-oesophageal reflux monitoring - combined pH and impedance. Aliment Pharmacol Ther. 2006 Sep; 24 Suppl 2:27-37.
    View in: PubMed
    Score: 0.067
  10. The limitations of pH monitoring for detecting gastroesophageal reflux. Clin Gastroenterol Hepatol. 2006 Sep; 4(9):1184; author reply 1185.
    View in: PubMed
    Score: 0.067
  11. Nonacid reflux in patients with chronic cough on acid-suppressive therapy. Chest. 2006 Aug; 130(2):386-91.
    View in: PubMed
    Score: 0.067
  12. Effects of a 5-HT(4) receptor agonist on oesophageal function and gastro-oesophageal reflux: studies using combined impedance-manometry and combined impedance-pH. Aliment Pharmacol Ther. 2006 Jul 01; 24(1):155-62.
    View in: PubMed
    Score: 0.066
  13. Acid and non-acid reflux in patients with persistent symptoms despite acid suppressive therapy: a multicentre study using combined ambulatory impedance-pH monitoring. Gut. 2006 Oct; 55(10):1398-402.
    View in: PubMed
    Score: 0.065
  14. Esophageal pH monitoring: wireless does not mean worry less. J Clin Gastroenterol. 2006 Feb; 40(2):91-2.
    View in: PubMed
    Score: 0.064
  15. Do we need to rethink fundoplication for patients who have failed proton-pump-inhibitor therapy? Nat Clin Pract Gastroenterol Hepatol. 2006 Jan; 3(1):2-3.
    View in: PubMed
    Score: 0.064
  16. Nighttime reflux is primarily an early event. J Clin Gastroenterol. 2005 Aug; 39(7):579-83.
    View in: PubMed
    Score: 0.062
  17. Multichannel intraluminal impedance: general principles and technical issues. Gastrointest Endosc Clin N Am. 2005 Apr; 15(2):257-64.
    View in: PubMed
    Score: 0.061
  18. The influence of rapid food intake on postprandial reflux: studies in healthy volunteers. Am J Gastroenterol. 2004 Sep; 99(9):1645-51.
    View in: PubMed
    Score: 0.058
  19. Diagnosis of laryngopharyngeal reflux. Curr Opin Otolaryngol Head Neck Surg. 2004 Jun; 12(3):174-9.
    View in: PubMed
    Score: 0.057
  20. Twenty-four hour ambulatory simultaneous impedance and pH monitoring: a multicenter report of normal values from 60 healthy volunteers. Am J Gastroenterol. 2004 Jun; 99(6):1037-43.
    View in: PubMed
    Score: 0.057
  21. Nocturnal acid breakthrough: pH, drugs and bugs. Eur J Gastroenterol Hepatol. 2004 May; 16(5):441-3.
    View in: PubMed
    Score: 0.057
  22. Rumination documented by using combined multichannel intraluminal impedance and manometry. Clin Gastroenterol Hepatol. 2004 Apr; 2(4):340-3.
    View in: PubMed
    Score: 0.057
  23. Baclofen decreases acid and non-acid post-prandial gastro-oesophageal reflux measured by combined multichannel intraluminal impedance and pH. Aliment Pharmacol Ther. 2003 Jan; 17(2):243-51.
    View in: PubMed
    Score: 0.052
  24. Dose-dependent control of intragastric pH by pantoprazole, 10, 20 or 40 mg, in healthy volunteers. Aliment Pharmacol Ther. 2002 Apr; 16(4):829-36.
    View in: PubMed
    Score: 0.049
  25. Control of intragastric pH with omeprazole 20 mg, omeprazole 40 mg and lansoprazole 30 mg. Aliment Pharmacol Ther. 2001 May; 15(5):647-52.
    View in: PubMed
    Score: 0.046
  26. Proton pump inhibitors: better acid suppression when taken before a meal than without a meal. Aliment Pharmacol Ther. 2000 Oct; 14(10):1267-72.
    View in: PubMed
    Score: 0.045
  27. Effect of different recumbent positions on postprandial gastroesophageal reflux in normal subjects. Am J Gastroenterol. 2000 Oct; 95(10):2731-6.
    View in: PubMed
    Score: 0.045
  28. Gastric acidity and acid breakthrough with twice-daily omeprazole or lansoprazole. Aliment Pharmacol Ther. 2000 Jun; 14(6):709-14.
    View in: PubMed
    Score: 0.044
  29. Oesophageal motility defects associated with nocturnal gastro-oesophageal reflux on proton pump inhibitors. Aliment Pharmacol Ther. 1999 Nov; 13(11):1467-71.
    View in: PubMed
    Score: 0.042
  30. Influence of spontaneous sleep positions on nighttime recumbent reflux in patients with gastroesophageal reflux disease. Am J Gastroenterol. 1999 Aug; 94(8):2069-73.
    View in: PubMed
    Score: 0.041
  31. Bedtime ranitidine does not eliminate the need for a second daily dose of omeprazole to suppress nocturnal gastric pH. Aliment Pharmacol Ther. 1999 May; 13(5):675-8.
    View in: PubMed
    Score: 0.040
  32. Ranitidine controls nocturnal gastric acid breakthrough on omeprazole: a controlled study in normal subjects. Gastroenterology. 1998 Dec; 115(6):1335-9.
    View in: PubMed
    Score: 0.039
  33. Nocturnal gastric acidity and acid breakthrough on different regimens of omeprazole 40 mg daily. Aliment Pharmacol Ther. 1998 Dec; 12(12):1235-40.
    View in: PubMed
    Score: 0.039
  34. Normal patterns of acid exposure at the gastric cardia: a functional midpoint between the esophagus and stomach. Am J Gastroenterol. 1998 Aug; 93(8):1236-42.
    View in: PubMed
    Score: 0.038
  35. Nocturnal recovery of gastric acid secretion with twice-daily dosing of proton pump inhibitors. Am J Gastroenterol. 1998 May; 93(5):763-7.
    View in: PubMed
    Score: 0.038
  36. Effects of omeprazole versus placebo in treatment of noncardiac chest pain and gastroesophageal reflux. Dig Dis Sci. 1997 Oct; 42(10):2138-45.
    View in: PubMed
    Score: 0.036
  37. Effective gastric acid suppression after oral administration of enteric-coated omeprazole granules. Dig Dis Sci. 1997 Apr; 42(4):715-9.
    View in: PubMed
    Score: 0.035
  38. Persistent acid secretion during omeprazole therapy: a study of gastric acid profiles in patients demonstrating failure of omeprazole therapy. Am J Gastroenterol. 1996 Aug; 91(8):1527-31.
    View in: PubMed
    Score: 0.033
  39. Approach to the patient with unexplained chest pain. Mt Sinai J Med. 1994 Nov; 61(6):476-83.
    View in: PubMed
    Score: 0.030
  40. Does the intraesophageal pH probe accurately detect acid reflux? Simultaneous recording with two pH probes in humans. Dig Dis Sci. 1989 May; 34(5):649-56.
    View in: PubMed
    Score: 0.020
  41. Ambulatory 24-hour esophageal pH monitoring. Reproducibility and variability of pH parameters. Dig Dis Sci. 1988 Sep; 33(9):1127-33.
    View in: PubMed
    Score: 0.019
  42. The symptom index: a clinically important parameter of ambulatory 24-hour esophageal pH monitoring. Am J Gastroenterol. 1988 Apr; 83(4):358-61.
    View in: PubMed
    Score: 0.019
  43. Abbreviated Histalog gastric analysis. Comparison with peak acid output. Am J Dig Dis. 1967 Jul; 12(7):713-9.
    View in: PubMed
    Score: 0.018
  44. Review article: acidity and volume of the refluxate in the genesis of gastro-oesophageal reflux disease symptoms. Aliment Pharmacol Ther. 2007 May 01; 25(9):1003-17.
    View in: PubMed
    Score: 0.018
  45. The acidity index: a simple approach to the measurement of gastric acidity. Aliment Pharmacol Ther. 2004 Feb 15; 19(4):443-8.
    View in: PubMed
    Score: 0.014
  46. The Stretta procedure for the treatment of GERD: 6 and 12 month follow-up of the U.S. open label trial. Gastrointest Endosc. 2002 Feb; 55(2):149-56.
    View in: PubMed
    Score: 0.012
  47. In support of the clinical usefulness of lower esophageal sphincter pressure determination. Dig Dis Sci. 1981 Nov; 26(11):1028-31.
    View in: PubMed
    Score: 0.012
  48. Abnormal gastric emptying response to pentagastrin in duodenal ulcer disease. Dig Dis Sci. 1981 Apr; 26(4):292-6.
    View in: PubMed
    Score: 0.012
  49. Altered gastric emptying and secretion in primary anorexia nervosa. Gastroenterology. 1979 Aug; 77(2):319-23.
    View in: PubMed
    Score: 0.010
  50. Hormonal control of gastroesophageal-sphincter strength. N Engl J Med. 1970 Apr 16; 282(16):886-9.
    View in: PubMed
    Score: 0.005
  51. A comparison of high and low fat meals on postprandial esophageal acid exposure. Am J Gastroenterol. 1989 Jul; 84(7):782-6.
    View in: PubMed
    Score: 0.005
  52. Effect of prostacyclin on gastric emptying and secretion in rhesus monkeys. Gastroenterology. 1980 Jun; 78(6):1476-9.
    View in: PubMed
    Score: 0.003
  53. Measurements and comparisons of lower esophageal sphincter pressures and serum gastrin levels in patients with gastroesophageal reflux. Gastroenterology. 1974 Sep; 67(3):415-22.
    View in: PubMed
    Score: 0.002
  54. Gastric acid secretion in infectious hepatitis. Mil Med. 1972 Feb; 137(2):64-6.
    View in: PubMed
    Score: 0.002
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.